The shares of HEALTHSOUTH Corp. (NYSE:HLS) currently has mean rating of 2.25 while 2 analysts have recommended the shares as “BUY”, 6 recommended as “OUTPERFORM” and 3 recommended as “HOLD”. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for sell.
The company’s mean estimate for sales for the current quarter ending Jun 16 is 905.02M by 11 analysts. The means estimate of sales for the year ending Dec-16 is 3.67B by 11 analysts.
The mean price target for the shares of HEALTHSOUTH Corp. (HLS) is at 44.73 while the highest price target suggested by the analysts is 50.00 and low price target is 37.00. The mean price target is calculated keeping in view the consensus of 11 brokerage firms.
The average estimate of EPS for the current fiscal quarter for HEALTHSOUTH Corp. (HLS) stands at 0.60 while the EPS for the current year is fixed at 2.46 by 11 analysts.
The next one year’s EPS estimate is set at 2.70 by 11 analysts while a year ago the analysts suggested the company’s EPS at 2.46. The analysts also projected the company’s long-term growth at 10.87% for the upcoming five years.
In its latest quarter ended on 31st March 2016, HEALTHSOUTH Corp. (HLS) reported earnings of $0.61. The posted earnings topped the analyst’s consensus by $0.06 with the surprise factor of 10.90%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.
On May 5, 2016 HEALTHSOUTH Corp. (HLS) announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.23 per share, payable on July 15, 2016, to holders of record on July 1, 2016.
The Company’s 2.0% Convertible Senior Subordinated Notes are convertible, at the option of the holder, at any time prior to the close of business on the business day immediately preceding December 1, 2043 into shares of common stock at a conversion rate of 26.6011 shares of common stock per $1,000 principal and include antidilutive protection that provides for an increase in the number of shares of common stock issuable upon conversion resulting from common stock dividends after a de minimis threshold. The dividend payment in July likely will not trigger this antidilutive adjustment. Subsequent declaration and payment of dividends on HealthSouth common stock may require an adjustment.